PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Identifies how quickly the company is scaling its balance sheet (via acquisitions, expansions, or debt). Strong growth, accompanied by sound fundamentals, can support long-term intrinsic value—while disproportionate debt expansion or bloated intangible assets can signal elevated risk.
-3.88%
Cash & equivalents declining -3.88% while Healthcare shows -7.98% growth. Howard Marks would investigate if this cash drain is temporary or signals deeper issues.
No Data
No Data available this quarter, please select a different quarter.
-3.88%
Cash + STI yoy growth 0.5-0.75x the Healthcare median of -7.16%. Guy Spier would be cautious about potential underfunding of liquidity.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-10.86%
Exceeding 1.5x Healthcare median of 0.00%. Jim Chanos might suspect questionable capitalization or one-time items inflating current assets.
-4.12%
Near the Healthcare median of -4.04%. Charlie Munger sees typical short-term asset management among peers.
-3.46%
PP&E growth ≥ 1.5x the Healthcare median of -0.62%. Joel Greenblatt sees aggressive expansion. Check if revenue growth supports it.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Above 1.5x Healthcare median of 0.00%. Jim Chanos sees a red flag for intangible or questionable expansions in the balance sheet.
-3.14%
≥ 1.5x the Healthcare median of -0.70%. Joel Greenblatt sees more aggressive long-term asset growth than peers, but it must be value-accretive.
No Data
No Data available this quarter, please select a different quarter.
-4.09%
≥ 1.5x the Healthcare median of -2.40%. Joel Greenblatt sees more aggressive asset expansion than peers, but must confirm returns are adequate.
36.45%
Payables growth above 1.5x Healthcare median of 0.00%. Jim Chanos might see a warning sign of stressed supplier payments.
25.40%
Above 1.5x Healthcare median of 0.00%. Jim Chanos might see a short-term leverage spike, raising red flags for near-term solvency.
No Data
No Data available this quarter, please select a different quarter.
-55.39%
Below half Healthcare median of 0.00%. Jim Chanos sees a potential sales pipeline shortfall.
-25.40%
Above 1.5x Healthcare median of 0.00%. Jim Chanos suspects a potential short-term burden spike.
32.92%
Above 1.5x Healthcare median of 2.41%. Jim Chanos suspects potential working capital strain.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-0.34%
Below half Healthcare median of -1.70%. Joel Greenblatt sees more conservative long-term liability expansion vs. peers.
No Data
No Data available this quarter, please select a different quarter.
4.45%
Above 1.5x Healthcare median of 0.00%. Jim Chanos suspects an alarming rise in overall leverage.
No Data
No Data available this quarter, please select a different quarter.
-3.53%
Near Healthcare median of -3.27%. Charlie Munger sees typical yoy changes in retained earnings.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-8.86%
≥ 1.5x Healthcare median of -3.45%. Joel Greenblatt sees stronger equity growth vs. peers.
-4.09%
≥ 1.5x Healthcare median of -2.45%. Joel Greenblatt sees more aggressive expansions than peers.
No Data
No Data available this quarter, please select a different quarter.
-1.77%
Above 1.5x Healthcare median of -0.60%. Jim Chanos suspects a big rise in leverage. Check coverage carefully.
3.93%
50-75% of Healthcare median 7.36%. Mohnish Pabrai notes comparatively lower net debt growth.